Quels sont les frais de l'ETF VHT ?

Les frais courants déclarés sont de 0,09 % par an. Des frais de 0,09 % par an représentent 9 € prélevés chaque année pour 10 000 € investis, directement dans la valeur de la part.

Quelles sont les plus grosses positions de Vanguard Health Care ETF ?

Les dix premières lignes pèsent 51,8 % du fonds : Eli Lilly and Company (12,9 %), Johnson & Johnson (8,8 %), AbbVie Inc. (6,5 %), Merck & Co., Inc. (5,0 %), UnitedHealth Group Incorporated (4,7 %).

L'ETF VHT est-il éligible au PEA ?

Non : le fonds est domicilié hors de l'Espace économique européen (ISIN US92204A5048), il n'est pas logeable dans un PEA. Il reste accessible en compte-titres.

Quelle est la performance de VHT sur 5 ans ?

+32,0 % sur 5 ans, soit +5,7 % par an, en USD et dividendes non réinvestis (cours de clôture au 2026-11-06).

Vanguard Health Care ETF (VHT): fees, AUM, composition and performance

Annual fees

0,09 %

deducted from the share value

Outstanding

21,80 $bn

in US dollars

Number of lines

416

published positions

Weight of the top 10

51,8 %

concentration

Performance 1 year

+25,4 %

price in USD

3 year performance

+46,7 %

i.e. +13,6 % per year

5 year performance

+32,0 %

i.e. +5,7 % per year

Volatilité 1 an

16,4 %

annualized standard deviation

Worst drop

-17,9 %

from a high, 5 years

Last share price

341,23 USD

+0,01 % during the session

Reading. Fees of 0,09 % per year represent 9 € collected each year for every 10 000 € invested, directly in the share value. Healthcare ETFs mix pharmaceuticals, medical equipment and biotechnologies: a defensive sector in the United States, more cyclical in its biotech part. The positions come from the issuer's publications; performance is calculated on the closing prices of the VHT listing, dividends not reinvested, in the listing currency.

10 first linesweight in the fund

Eli Lilly and CompanyUS5324571083

12,93 %

Johnson & JohnsonUS4781601046

8,78 %

AbbVie Inc.US00287Y1091

6,45 %

Merck & Co., Inc.US58933Y1055

5,01 %

UnitedHealth Group IncorporatedUS91324P1021

4,65 %

Thermo Fisher Scientific Inc.US8835561023

3,50 %

Amgen Inc.US0311621009

3,18 %

Gilead Sciences, Inc.US3755581036

2,58 %

Abbott LaboratoriesUS0028241000

2,40 %

Pfizer Inc.US7170811035

2,27 %

Sectorsaccording to the issuer

Health

99,95 %

Finance

0,03 %

Industry

0,01 %

Technology

0,01 %

Countryaccording to the issuer

United States

100,00 %

What you need to know

The first 10 lines make up more than half of the fund: it behaves like a basket of a few securities.

Composition: the 50 largest positions

#	Line	Weight	Value
1	Eli Lilly and CompanyUS5324571083	12,93 %	2,83 $bn
2	Johnson & JohnsonUS4781601046	8,78 %	1,92 $bn
3	AbbVie Inc.US00287Y1091	6,45 %	1,41 $bn
4	Merck & Co., Inc.US58933Y1055	5,01 %	1,10 $bn
5	UnitedHealth Group IncorporatedUS91324P1021	4,65 %	1,02 $bn
6	Thermo Fisher Scientific Inc.US8835561023	3,50 %	766,6 M$
7	Amgen Inc.US0311621009	3,18 %	695,2 M$
8	Gilead Sciences, Inc.US3755581036	2,58 %	565,5 M$
9	Abbott LaboratoriesUS0028241000	2,40 %	526,0 M$
10	Pfizer Inc.US7170811035	2,27 %	496,7 M$
11	Intuitive Surgical, Inc.US46120E6023	2,01 %	440,1 M$
12	Danaher CorporationUS2358511028	1,97 %	431,3 M$
13	Vertex Pharmaceuticals IncorporatedUS92532F1003	1,85 %	405,5 M$
14	Bristol-Myers Squibb CompanyUS1101221083	1,78 %	389,4 M$
15	Medtronic plcIE00BTN1Y115	1,54 %	337,5 M$
16	CVS Health CorporationUS1266501006	1,53 %	334,1 M$
17	McKesson CorporationUS58155Q1031	1,40 %	305,5 M$
18	Stryker CorporationUS8636671013	1,33 %	290,3 M$
19	Elevance Health Inc.US0367521038	1,14 %	250,3 M$
20	Regeneron Pharmaceuticals, Inc.US75886F1075	1,09 %	238,7 M$
21	Cigna CorporationUS1255231003	1,00 %	219,7 M$
22	HCA Healthcare, Inc.US40412C1018	0,93 %	202,5 M$
23	Moderna, Inc.US60770K1079	0,91 %	198,5 M$
24	Boston Scientific CorporationUS1011371077	0,91 %	198,3 M$
25	Natera, Inc.US6323071042	0,79 %	171,8 M$
26	Cencora, Inc.US03073E1055	0,77 %	169,6 M$
27	Cardinal Health, Inc.US14149Y1082	0,73 %	159,2 M$
28	Edwards Lifesciences CorporationUS28176E1082	0,69 %	151,9 M$
29	Becton, Dickinson and CompanyUS0758871091	0,69 %	150,7 M$
30	Agilent Technologies, Inc.US00846U1016	0,68 %	148,7 M$
31	Humana Inc.US4448591028	0,64 %	140,0 M$
32	IQVIA Holdings Inc.US46266C1053	0,63 %	137,1 M$
33	Waters CorporationUS9418481035	0,60 %	131,8 M$
34	Veeva Systems Inc.US9224751084	0,58 %	127,5 M$
35	IDEXX Laboratories, Inc.US45168D1046	0,57 %	125,9 M$
36	Illumina, Inc.US4523271090	0,56 %	123,3 M$
37	Revolution Medicines, Inc.US76155X1000	0,49 %	106,7 M$
38	Biogen Inc.US09062X1037	0,47 %	101,9 M$
39	DexCom, Inc.US2521311074	0,46 %	101,7 M$
40	Alnylam Pharmaceuticals, Inc.US02043Q1076	0,46 %	100,7 M$
41	ResMed Inc.US7611521078	0,45 %	97,4 M$
42	Centene CorporationUS15135B1017	0,43 %	93,7 M$
43	Mettler-Toledo International Inc.US5926881054	0,43 %	93,3 M$
44	GE HealthCare Technologies Inc.US36266G1076	0,42 %	90,9 M$
45	Zoetis Inc.US98978V1035	0,41 %	89,4 M$
46	West Pharmaceutical Services, Inc.US9553061055	0,37 %	80,0 M$
47	Quest Diagnostics IncorporatedUS74834L1008	0,36 %	78,8 M$
48	Labcorp Holdings Inc.US5049221055	0,35 %	77,2 M$
49	Insmed IncorporatedUS4576693075	0,34 %	73,7 M$
50	Tenet Healthcare CorporationUS88033G4073	0,31 %	67,3 M$

Comparable ETFs

The overlap measures the part of the portfolio common to both funds (sum of minimum weights on shared lines): beyond 70 %, holding both provides almost no diversification.

ETF	Fees	Outstanding	Perf. 1 year	Recovery
Fidelity MSCI Health Care Index ETFFHLC · Fidelity	0,08 %	3,54 $bn	+25,8 %	96,5 %	compare
iShares U.S. Healthcare ETFIYH · IShares	0,37 %	4,64 $bn	+26,2 %	87,2 %	compare
State Street Health Care Select Sector SPDR ETFXLV · SPDR	0,08 %	48,47 $bn	+26,6 %	85,2 %	compare
iShares S&P 500 Health Care Sector UCITS ETFQDVG.DE · IShares	0,15 %	3,56 $bn	+33,1 %	85,2 %	compare
Xtrackers MSCI World Health Care UCITS ETF 1CXDWH.DE · Xtrackers	0,25 %	4,54 $bn	+27,0 %	73,6 %	compare
iShares Global Healthcare ETFIXJ · IShares	0,38 %	4,65 $bn	+23,0 %	73,0 %	compare
GMO US Quality ETFQLTY · GMO	0,50 %	5,40 $bn	+17,0 %	22,0 %	compare
iShares Future Exponential Technologies ETFXT · IShares	0,46 %	3,98 $bn	+8,2 %	20,6 %	compare

Its holdings in other ETFsdouble exposure

The top holdings of VHT are found in many other funds: combining several ETFs often means holding the same companies multiple times.

Eli Lilly and Company : 12,93 % in this fund; held by 992 ETF, 208,56 Bn$ in total
Johnson & Johnson : 8,78 % in this fund; held by 927 ETF, 122,26 Bn$ in total
AbbVie Inc. : 6,45 % in this fund; held by 923 ETF, 90,46 Bn$ in total
Merck & Co., Inc. : 5,01 % in this fund; held by 965 ETF, 73,94 Bn$ in total
UnitedHealth Group Incorporated : 4,65 % in this fund; held by 828 ETF, 73,86 Bn$ in total
Thermo Fisher Scientific Inc. : 3,50 % in this fund; held by 647 ETF, 42,13 Bn$ in total
Amgen Inc. : 3,18 % in this fund; held by 899 ETF, 63,41 Bn$ in total
Gilead Sciences, Inc. : 2,58 % in this fund; held by 933 ETF, 48,27 Bn$ in total

Information provided for educational purposes from the positions published by the issuers and closing prices. Past performance is not indicative of future performance; fees and assets under management are those declared by the source and may contain errors. Investing involves a risk of capital loss.

Vanguard Health Care ETF (VHT)